Furmonertinib
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis (NCT07348965) | Guangzhou University of Traditional Chinese Medicine | 2026-03-01 |
| Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study (NCT07365410) | Tianjin Medical University Cancer Institute and Hospital | 2026-01-01 |
| Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE) (NCT05465343) | Peking Union Medical College | 2022-07-11 |
Track Furmonertinib automatically
Every clearance here is in the API, with alerts when new ones post.